Lilly Stomach Cancer Drug Prolongs Life in Colon Cancer Study

The gist: A drug used to treat stomach cancer may also help treat people with advanced colorectal cancer. The drug, called Cyramza, was tested in a clinical trial—a research study with volunteer patients. The trial involved patients who had not been treated successfully with other approaches.

“Eli Lilly and Co’s LLY.N Cyramza stomach-cancer drug prolonged survival of patients with advanced colon cancer in a late-stage study, the U.S. drugmaker said on Friday.

“Based on favorable data from the Phase III study, Lilly said it would ask regulators in the first half of 2015 to approve Cyramza in patients with colorectal cancer that has spread to other parts of the body. It plans to present detailed results from the trial at a scientific meeting next year.

“The 1,000-patient global study, called RAISE, involved patients who had previously failed to adequately benefit from Roche Holding AG’s ROG.VX Avastin and other standard treatments.

“Patients taking Cyramza along with chemotherapy showed a statistical improvement in survival, compared with those in the study who took a placebo and chemotherapy.”